Amylin Pharmaceuticals to Present at UBS Global Life Sciences Conference
September 22 2004 - 8:15AM
PR Newswire (US)
Amylin Pharmaceuticals to Present at UBS Global Life Sciences
Conference SAN DIEGO, Sept. 22 /PRNewswire-FirstCall/ -- Amylin
Pharmaceuticals, Inc. (NASDAQ:AMLN) will be presenting at the UBS
Global Life Sciences Conference on Monday, September 27th at 10:00
a.m. ET in New York. Daniel M. Bradbury, Chief Operating Officer of
Amylin Pharmaceuticals, will be providing a corporate overview,
which will include a review of the company's development programs.
The live presentation and breakout session will both be webcast,
and recordings will be made available following the events. The
webcasts and recordings will be accessible through Amylin's
corporate website, located at http://www.amylin.com/. To access the
live webcasts, please log on to Amylin's site approximately fifteen
minutes prior to the presentation to register and download any
necessary audio software. Amylin Pharmaceuticals is committed to
improving the lives of people with diabetes and other metabolic
diseases through the discovery, development and commercialization
of innovative, cost-effective medicines. DATASOURCE: Amylin
Pharmaceuticals, Inc. CONTACT: Mark G. Foletta, Vice President of
Finance and Chief Financial Officer of Amylin Pharmaceuticals,
Inc., +1-858-552-2200 Web site: http://www.amylin.com/
Copyright
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jun 2024 to Jul 2024
Amylin Pharmaceuticals, Inc. (MM) (NASDAQ:AMLN)
Historical Stock Chart
From Jul 2023 to Jul 2024